Skip to Main Content

Author Details

Patrick K Ha
University of California San Francisco
1998
153
40
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35965473Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.Cancer Epidemiol Biomarkers Prev2023
37627108Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications.Cancers (Basel)2023
37210888Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone.Am J Otolaryngol2023
34182836Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.Otolaryngol Head Neck Surg2022
35798312The Role of ECM Remodeling, EMT, and Adhesion Molecules in Cancerous Neural Invasion: Changing Perspectives.Adv Biol (Weinh)2022
35565392Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.Cancers (Basel)2022
35715306Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue.Brachytherapy2022
36428790Approaches to the Management of Metastatic Adenoid Cystic Carcinoma.Cancers (Basel)2022
35929989STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.Clin Cancer Res2022
35132635Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.Cancer2022
35158773NSAIDs Overcome <i>PIK3CA</i> Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models.Cancers (Basel)2022
35022323Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.Clin Cancer Res2022
34894450Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.Am J Otolaryngol2022
32396214Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer.Laryngoscope2021
33513477Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma.Am J Otolaryngol2021
33900808Management of Salivary Gland Malignancy: ASCO Guideline.J Clin Oncol2021
33582667Patient-Reported Outcomes of Split-Thickness Skin Grafts for Floor of Mouth Cancer Reconstruction.ORL J Otorhinolaryngol Relat Spec2021
34673904Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.JAMA Otolaryngol Head Neck Surg2021
34401492A prospective study of patient-reported xerostomia-related outcomes after parotidectomy.Laryngoscope Investig Otolaryngol2021
34626024Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.Head Neck2021
34304004Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.Oral Oncol2021
33957701Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.Cancer2021
34143891RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.Cancer2021
34194767Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette-Guérin therapy for urothelial carcinoma in situ.Clin Case Rep2021
34024488Molecular Markers that Matter in Salivary Malignancy.Otolaryngol Clin North Am2021
33408119Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.Cancer Res2021
33165092MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status.Am J Surg Pathol2021
33426652Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.Cancer2021
33246539PET/CT in Surgical Planning for Head and Neck Cancer.Semin Nucl Med2021
32379355Patient-Reported Quality of Life After Resection With Primary Closure for Oral Tongue Carcinoma.Laryngoscope2021
30919470Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.Laryngoscope2020
31934915HPV-positive Squamous Cell Carcinoma of the Larynx, Oral Cavity, and Hypopharynx: Clinicopathologic Characterization With Recognition of a Novel Warty Variant.Am J Surg Pathol2020
31990084Machine Learning for Predicting Complications in Head and Neck Microvascular Free Tissue Transfer.Laryngoscope2020
32101350Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.Head Neck2020
32098320Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma.Cells2020
31881446Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.Oral Oncol2020
33437800De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma-a narrative review.Ann Transl Med2020
32571145The Role of Age and Merkel Cell Polyomavirus in Oral Cavity Cancers.Otolaryngol Head Neck Surg2020
32650834Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.J Otolaryngol Head Neck Surg2020
32400948Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.Head Neck2020
31411752Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma.Laryngoscope2020
30500293Data Set for the Reporting of Carcinomas of the Major Salivary Glands: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.Arch Pathol Lab Med2019
30149772Effects of a Comprehensive Performance Improvement Strategy on Postoperative Adverse Events in Head and Neck Surgery.Otolaryngol Head Neck Surg2019
30170906Advanced head and neck surgical techniques: A survey of US otolaryngology resident perspectives.Auris Nasus Larynx2019
31373686Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.Int J Cancer2019
31228426Can Early Dental Extractions Reduce Delays in Postoperative Radiation for Patients With Advanced Oral Cavity Carcinoma?J Oral Maxillofac Surg2019
31483290Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.J Clin Invest2019
31097695Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
30829856Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT.Clin Nucl Med2019
31142745Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
  • 1 - 50 of 153

Recommended Authors

David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 2
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 1
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 8
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 12
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 1
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 11
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 1
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 9
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 12
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 14
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 19
University of British Columbia
Career Start Year 2000
Number of shared co-authors 2
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 19
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 11
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 9
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 4
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 13
Location Vrije Universiteit Amsterdam
Career Start Year 1990
Number of shared co-authors 12
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1988
Number of shared co-authors 13
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 13
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 4
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 8

Collaborators

University of California
Co-authored papers 62
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 31
Johns Hopkins University School of Medicine
Co-authored papers 19
UT Southwestern Medical Center
Co-authored papers 13
Moores Cancer Center, University of California
Co-authored papers 7
Johns Hopkins University School of Medicine
Co-authored papers 7
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 7
Johns Hopkins University
Co-authored papers 6
Johns Hopkins University School of Medicine
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Johns Hopkins School of Medicine
Co-authored papers 5
University of Pittsburgh Medical Center-Presbyterian
Co-authored papers 4
Duke University Medical Center
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 4
MD Anderson Cancer Center
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
University of Texas at Houston Health Science Center
Co-authored papers 3
University of Pittsburgh School of Medicine
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 3
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 3
Tokai University
Co-authored papers 3
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Chinese University of Hong Kong
Co-authored papers 2
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 2
University of California San Diego
Co-authored papers 2
Moores Cancer Center, University of California
Co-authored papers 2